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Background: While many studies have demonstrated positive associations between childhood obesity and adult metabolic risk,
important questions remain as to the nature of the relationship. In particular, it is unclear whether the associations reflect the
tracking of body mass index (BMI) from childhood to adulthood or an independent level of risk. This systematic review aimed
to investigate the relationship between childhood obesity and a range of metabolic risk factors during adult life.
Objective: To perform an unbiased systematic review to investigate the association between childhood BMI and risk of
developing components of metabolic disease in adulthood, and whether the associations observed are independent of adult
BMI.
Design: Electronic databases were searched from inception until July 2010 for studies investigating the association between
childhood BMI and adult metabolic risk. Two investigators independently reviewed studies for eligibility according to the
inclusion/exclusion criteria, extracted the data and assessed study quality using the Newcastle–Ottawa Scale.
Results: The search process identified 11 articles that fulfilled the inclusion and exclusion criteria. Although several identified
weak positive associations between childhood BMI and adult total cholesterol, low-density lipo protein-cholesterol, triglyceride
and insulin concentrations, these associations were ameliorated or inversed when adjusted for adult BMI or body fatness. Of the
four papers that considered metabolic syndrome as an end point, none showed evidence of an independent association with
childhood obesity.
Conclusions: Little evidence was found to support the view that childhood obesity is an independent risk factor for adult blood
lipid status, insulin levels, metabolic syndrome or type 2 diabetes. The majority of studies failed to adjust for adult BMI and
therefore the associations observed may reflect the tracking of BMI across the lifespan. Interestingly, where adult BMI was
adjusted for, the data showed a weak negative association between childhood BMI and metabolic variables, with those at the
lower end of the BMI range in childhood, but obese during adulthood at particular risk.
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Introduction
Overweight and obesity are associated with a range of
chronic disease states, including cardiovascular disease
(CVD), type 2 diabetes and certain cancers. The World
Health Organisation has estimated that around a third of
coronary heart disease and ischaemic stroke cases are
attributable to excess adiposity.1 Current prevalence of
overweight and obesity therefore has significant implica-
tions for population morbidity and mortality, and in this
regard the rising prevalence of childhood obesity is of
particular concern. In the United Kingdom, 2004 figures
showed the prevalence of obesity in children aged 5–17
years to be 29%,2 and most estimates suggest a doubling in
prevalence over the course of the preceding decade.3,4
Similarly in the United States, 32% of children and
adolescents were observed to be at or above the 85th
percentile of the 2000 body mass index (BMI)-for-age growth
charts.5,6 Such data are predictive of adult overweight and
obesity rates in the future, as adiposity has been shown to
track from childhood into adult life.7,8 It is generally
assumed that an earlier onset and longer duration of obesity
is associated with a greater cardiovascular risk, increasing
concern about childhood obesity trends.
Although many studies have demonstrated positive asso-
ciations between childhood obesity and adult cardiovascular
risk, important questions remain as to the nature of the
relationship.9 For example, it is not clear whether weight loss
Received 8 February 2011; revised 14 April 2011; accepted 22 April 2011;
published online 1 November 2011
Correspondence: Dr S McMullen, Division of Nutritional Sciences, School
of Biosciences, University of Nottingham, Sutton Bonington Campus,
Loughborough LE12 5RD, UK.
E-mail: sarah.mcmullen@nottingham.ac.uk
International Journal of Obesity (2012) 36, 1–11
& 2012 Macmillan Publishers Limited All rights reserved 0307-0565/12
www.nature.com/ijo
interventions in adult life can fully ameliorate the risks
associated with childhood obesity, or whether an indepen-
dent effect of childhood obesity remains, irrespective of the
degree of adult adiposity. This has major implications for the
design and timing of appropriate public health interven-
tions. Our recent systematic review suggested that the
observed associations between childhood obesity and adult
blood pressure, carotid intima–media thickness or cardio-
vascular events largely reflected the tracking of BMI from
childhood into adult life, and concluded that there was little
evidence of an association that was independent of adult
BMI.10 The data suggested that avoiding overweight during
childhood failed to provide any protection against the effects
of obesity in adulthood, and that those who were obese
children but went on to be normal weight adults were not at
any greater risk of CVD. Interestingly, those who were lean as
children seemed to be most susceptible to the risks associated
with adult obesity, particularly with respect to high blood
pressure. Lauer et al.11 also observed that the strongest
predictor of blood pressure was a change from being at the
lower end of the BMI scale in children to the higher end in
adulthood. Li et al.12 reported that the effect of adult BMI on
blood pressure was highest in those who had been in the
lowest BMI decile as children. These associations remain
unexplained, but may reflect the differing contributions of
lean body mass to BMI across the lifespan and the
cumulative effect of changes in body composition over time.
The nature of these observations indicates a complexity in
the relationship between obesity and metabolic risk across
the lifespan, which is worthy of further study.
This second systematic review builds upon that published
previously, with the aim of assessing the relationship between
childhood obesity and a range of metabolic risk factors related
to cardiovascular health during adult life. The inclusion criteria
for this review focused on the selection of studies focusing on
the wider components of the metabolic syndrome, including
dyslipidaemia, insulin resistance and metabolic disease out-
comes. This has enabled more detailed investigation of the
important research questions regarding the long-term impact
of childhood obesity, which arose from the previous review.
Materials and methods
The general methods of systematic review used in this study
were as previously described in Lloyd et al.10 Briefly, we
reviewed the literature reporting results from longitudinal
studies investigating the association between childhood
obesity and adult metabolic disease risk. A computerised
search of the online electronic databases PubMed (MEDLINE)
and ISI Web of Science from inception up to 30 June 2010
was carried out, using the terms ‘childhood’, ‘adult’ and
‘obesity’. The selection process and number of articles
excluded at each stage are shown in Figure 1.
Two investigators (LJL and SM) independently reviewed
studies for eligibility according to the criteria below.
Agreement was good (k¼99%) and any differences were
agreed by consensus.
The inclusion criteria were as follows:
1. Childhood measures of BMI at one or more ages in
childhood (0–12) or adolescence.13–18 All measurements
taken by health professionals or trained investigators.
2. Childhood BMI status calculated using US Centre for
Disease Control percentile charts5 or International Obesity
Task Force charts,13 and childhood overweight and obese
defined as within those criteria (Centre for Disease
Control: 485th centile¼ at risk of overweight, 495th
centile¼overweight; International Obesity Task Force
percentiles track back from World Health Organisation
adult guidelines14 of X25 kgm2 overweight and
X30kgm2 obese). Or childhood BMI treated as a
continuous variable and association with adult outcome
assessed by regression or correlation.
3. Adult overweight and obese defined according to World
Health Organisation guidelines14 as overweight when
BMI X25kgm2 and obese when BMI X30kgm2.
4. One or more biomarkers of metabolic disease risk
measured at one or more ages in adulthood (defined as
418 years of age), for example, cholesterol, triglycerides
and plasma insulin. All measurements were taken by
health professionals or trained investigators. Or metabolic
disease outcomes/cause of death extracted from secure
registers.
5. Studies carried out in westernised, developed countries.
6. Articles in English language.
The exclusion criteria were as follows:
1. Studies where participants were part of an obesity
intervention/health promotion programme.
2. Studies where the individuals involved were all part of a
selected group, for example, asthmatics, childhood cancer
survivors, preterm babies, and so on.
3. Studies in which exposure or outcome had been self-reported.
4. Childhood or adult overweight/obese defined using
arbitrary cutoff points.
5. Reviews, rather than original data.
Data extraction and quality assessment
Data were extracted as described previously.10 In short,
regression or correlation coefficients, or hazard ratios or
relative risks and confidence intervals were extracted,
together with the statistical significance of the associations
(where provided). These data are summarised in Table 1.
Quality of the papers that passed the defined criteria for
inclusion in the review was assessed using the Newcastle–
Ottawa Scale, based on recommendations by the Cochrane
Non-Randomised Studies Methods Working group, as
described previously.10 Two investigators (LJL and SM)
independently assessed study quality according to the
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criteria in Table 2. Agreement was good (k¼91.4%) and
differences were agreed by consensus. Results from the
quality assessment are summarised in Table 3.
Results
In all, 11 articles fulfilled the selection criteria and a
summary of the main characteristics and results is shown
in Table 1. All studies, apart from one, were published in the
last 10 years.
Quality assessment
Although a satisfactory degree of quality had been assured
through the inclusion/exclusion criteria, there was still some
variation between the quality assessments made using the
Newcastle–Ottawa Scale (Table 3). Based on sample selec-
tion, all studies were rated highly with one study attaining
four out of four possible stars15 and all others attaining three,
apart from Thearle et al.,16 which fulfilled only two of the
quality criteria. The studies with three stars all failed to show
the absence of the outcome of interest in childhood. Thearle
et al.16 studied Pima Indians, therefore failing to attain a star
for being truly representative of a westernised cohort. For
comparability there was more variation, with only one
study17 attaining both of the available stars, six rated one
star, three no stars and one study18 providing insufficient
information to make an assessment. This variation was due
to differences in accounting for confounding factors
(Table 2). Age and gender were generally accounted for, but
other confounding factors such as smoking or socioeco-
nomic status were unaccounted for in most of the studies.
Crucially, only four studies adjusted for current BMI or adult
percentage body fat, and as a result the majority of studies
was unable to draw valid conclusions regarding the inde-
pendent impact of childhood obesity upon metabolic
parameters.16,17,19,20 For assessment, seven studies attained
two stars and four studies rated three. Of those that attained
two, all were not awarded the third star because the adult
3025 citations in PubMed (MEDLINE)
and ISI Web of Science found by
electronic search
8 articles identified from
other sources
152 given more detailed
assessment
101 excluded after abstract
screen
2873 excluded after the title
screen
59 articles assessed
against inclusion/exclusion
criteria
11 studies included
48 excluded due to:
No childhood BMI measure
Other BMI criteria not met
Adult outcomes not relevant
Measurement criteria not met
Case-control studies
Reviews 5
3
2
13
11
14
Total 48
Figure 1 Flowchart of the search and selection process.
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cohort was considered too young (under 35) for the outcome
to be demonstrated adequately.
It was difficult to directly compare results across the
studies owing to the variety of statistical methods and
approaches used and this was the primary reason for not
performing a meta-analysis. Where relevant, regression
coefficients, odds ratios or estimates of relative risk were
extracted from the studies. Most studies treated childhood
BMI as a continuous variable for the purpose of statistical
analysis, but some used cutoff points (those recommended
by US Centre for Disease Control5 or International Obesity
Task Force13) to define childhood overweight or obese. In
addition, childhood BMI scores were sometimes presented as
z-scores, or as the change in BMI or BMI z-scores between age
categories.
The exposure variable (childhood BMI) was also measured
at substantially different ages, ranging from 2 to 18 years ofTa
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Table 2 Assessment of quality for a cohort study (adapted from Newcastle –
Ottawa Scale)
Selection
Representativeness of the intervention cohort:
K truly representative of children in the contemporary western world
somewhat representative of children in the contemporary western world
K selected group of patients, for example, only certain socioeconomic
groups/areas
K no description of the derivation of the cohort
Selection of the non-intervention cohort (in this case ‘normal weight’ during
childhood):
K drawn from the same community as the intervention cohort (in this case
‘at risk of overweight’ or ‘overweight/obese’ during childhood)
K drawn from a different source
K no description of the derivation of the non-intervention cohort
Ascertainment of exposure:
K measurement by trained health professional
secure record
K written self-report
K other/no description
Demonstration that outcome of interest was not present at the start of study:
K yes
K no
Comparability
Comparability of cohorts on the basis of the design or analysis:
K study controls for age, sex and adult BM/percentage body fat
K study controls for socioeconomic status
Outcome
Assessment of outcome:
K independent assessment by trained health-care professional
record linkage
K self-report
K other/no description
Was follow-up long enough for outcomes to occur:
K yes, if mean adult age 435
K no, if mean adult age p35
Adequacy of follow-up of cohorts:
K complete follow-up: all subjects accounted for
subjects lost to follow-up unlikely to introduce bias: number lost r20%,
or description of those lost suggesting no different from those followed
K follow-up rate o80% and no description of those lost
K no statement
Stars were awarded if the criteria shown in italics were met.
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age between studies. The age at which adult outcomes were
measured also varied widely from 18 to 71 years, with
historical cohort studies21 tending to include adult outcomes
at older ages than prospective studies. The year of birth in
the studies ranged from the 1930s21 up to the 1970s.22 –24
Some studies used one measure of childhood BMI, whereas
others used longitudinal data from the same study partici-
pants, and thus had more than one BMI measure in
childhood for each individual.
Generally the adult outcomes were more homogenous,
with total cholesterol, triglycerides and high-density lipopro-
tein (HDL)-cholesterol being measured by standard chemical
and/or enzymatic procedures as described in the Lipid
Research Clinics Program Manual of Laboratory Operations25
or by Lamont et al.26 low-density protein (LDL)-cholesterol
was calculated using the Friedewald equation.27 Fasting
insulin was measured using standard radioimmunoassay kits.
To determine insulin resistance, Martin et al.21 calculated
homeostasis model assessment (HOMA), and Thearle et al.16
calculated acute insulin response and insulin action. Defini-
tions of metabolic syndrome varied between studies. Sriniva-
san and co-workers15 defined those at risk of syndrome X as
being those individuals with the highest quartiles of BMI,
blood pressure, fasting insulin and total cholesterol:HDL-
cholesterol or triglycerides:HDL-cholesterol ratios. Morrison
et al.28 used the definition of metabolic syndrome as described
by the National Cholesterol Education Program expert panel
on detection, evaluation and treatment of high blood
cholesterol in adults.29 Salonen et al.17 used the criteria
defined by the International Diabetes Federation 2005.
Mortality and morbidity outcomes were identified from the
Cause of Death Registry at Statistics Norway.22
Table 3 Summary of results and quality scores
References Effect Adjusted effect Newcastle–Ottawa Scale
Selection (max. 4*) Comparability (max. 2*) Assessment (max. 3*)
Total cholesterol
Freedman et al.19 +  *** * **
Lauer et al.23 + Not adjusted *** * **
Sinaiko et al.24 2 Not adjusted *** **
Wright et al.20 ,2 ,2 *** * ***
LDL cholesterol
Freedman et al.19 +  *** * **
Sinaiko et al.24 2 Not adjusted *** **
Wright et al.20 2 2 *** * ***
HDL cholesterol
Freedman et al.19  + *** * **
Salonen et al.17 2 Not reported *** ** **
Sinaiko et al.24  Not adjusted *** **
Wright et al.20 2 2 *** * ***
Triglycerides
Freedman et al.19 +  *** * **
Salonen et al.17 2 Not reported *** ** **
Sinaiko et al.24 + Not adjusted *** **
Wright et al.20 ,2 ,2 *** * ***
Insulin
Freedman et al.19 +  *** * **
Freedman et al.18 + Not adjusteda *** a **
Martin et al.21 b Not adjusted *** * ***
Thearle et al.16 Not reported c, +d ** * **
Sinaiko et al.24 + Not adjusted *** **
Wright et al.20 2  *** * ***
Disease outcomes
Bjørge et al.22 2 Not adjusted *** ***
Morrison et al.28 + Not adjusted *** ***
Salonen et al.17   *** ** **
Srinivasan et al.15 + Not adjusted **** * **
Abbreviations: HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein. +, positive correlation; 2, no significant
correlation; , negative correlation; multiple annotations reflect differing associations found within paper, for example, at different age groups; anot reported;
bHOMA insulin resistance; cinsulin action; dacute insulin response. Stars (*) were awarded for selection, comparability and assessment according to the criteria in
Table 2.
Childhood obesity and adult metabolic syndrome
LJ Lloyd et al
6
International Journal of Obesity
Main results
Total cholesterol. Four studies considered the impact of
childhood BMI on adult total cholesterol concentrations
(Table 1), with two studies19,23 showing weak to moderate
positive correlations. One study20 reported a negative
correlation between BMI at age 9 and cholesterol in women
in adulthood, but no significant correlation with BMI at age
13 (no correlation observed in men at either age). Sinaiko
et al.24 showed no statistically significant association.
All four studies observed significant tracking of childhood
BMI into adulthood, but two studies23,24 did not adjust for
adult BMI, thus the independent effects of childhood BMI
were not investigated. Of the two studies that did adjust for
adult BMI, Freedman et al.19 reported a weak, negative
correlation between the two variables after adjustment and
Wright et al.20 observed that the weak negative correlation
between total cholesterol and BMI at age 9 in women
persisted.
LDL- and HDL-cholesterol. Three of the four studies men-
tioned above also looked at LDL- and HDL-cholesterol
concentrations.19,20,24 Freedman et al.19 showed a weak
positive correlation between childhood BMI and adult LDL-
cholesterol, but this became negative once adjusted for adult
BMI. They also reported the opposite for HDL-cholesterol,
that is, a weak negative correlation, which became positive
once adjusted for adult BMI. The two other studies20,24 did
not show any significant correlations between childhood
BMI and LDL-cholesterol, and this was still the case after
adjustment for adult BMI in the Wright et al. study.20 Wright
et al. reported the same findings regarding HDL-cholesterol,
that is, no significant correlation between childhood BMI
and HDL-cholesterol before or after adjusting for adult BMI.
Sinaiko et al.24 did show a significant but weakly negative
correlation between childhood BMI and HDL-cholesterol,
but did not adjust for adult BMI. This study was rated poorly
in the quality assessment (Table 3). Salonen et al.17 included
data for HDL-cholesterol as part of defining the metabolic
syndrome, but reported no significant correlations between
childhood BMI at any age and adult HDL-cholesterol.
However, it was not clear if this was adjusted for adult
percentage body fat or not.
Triglycerides. Two studies19,24 reported positive correlations
between childhood BMI and adult triglyceride concentra-
tions. One of these24 did not adjust for adult BMI despite
observing significant tracking of BMI into adulthood, hence
the independent effects of childhood BMI were not investi-
gated. Freedman et al.19 did adjust for adult BMI and found
the relationship inversed, that is, that a greater childhood
BMI was associated with lower circulating triglyceride
concentrations in adulthood. Another study17 reported no
significant correlation between the two variables, although it
was not clear if this was adjusted for adult body fat.
Conversely, Wright et al.20 reported a weak negative correla-
tion between childhood BMI at age 9 and adult triglyceride
concentrations in women, which became stronger once
adjusted for current BMI. However, no such associations
were seen at age 13, or at either time point for males.
Insulin. Six studies considered the impact of childhood BMI
on adult insulin concentrations or insulin resistance. Three
studies18,19,24 reported moderate positive correlations be-
tween childhood BMI and insulin concentrations. However,
the adjusted data set for Freedman et al.19 showed that this
association became negative once adjusted for current BMI.
The second paper by Freedman et al.18 did not report
whether or not the data were adjusted for adult BMI. Sinaiko
et al.24 did not make the adjustment, thus the independent
effects of childhood BMI were not assessed. Thearle et al.16
reported moderate positive correlations between childhood
BMI and adult acute insulin response and adult insulin
action, which were adjusted for adult percentage body fat,
therefore supporting an independent effect of childhood
BMI on these variables.
Interestingly, the two studies with the oldest adult cohorts
had contrasting findings to the literature relating to younger
populations. Wright et al.20 observed no significant correla-
tions between childhood BMI and adult insulin concentra-
tions, but a significant negative correlation became apparent
once adjusted for adult BMI. Martin et al.21 reported a
significantly lower homeostasis model assessment-insulin
resistance in adults who were of greater BMI during child-
hood. Homeostasis model assessment-insulin resistance fell
by 8% per standard deviation of increasing childhood BMI.
This study reported that the heaviest children were least
likely to manifest as insulin resistant in adulthood. This
tendency was particularly marked among children who went
on to become lean adults.
Disease outcomes. Four studies considered the impact of
childhood BMI on risk of type 2 diabetes and metabolic
syndrome in adulthood. Two studies showed positive
correlations between disease outcomes and childhood BMI.
Srinivasan et al.15 observed a positive relationship between
childhood BMI and the number of metabolic syndrome
criteria risk variables in adulthood. Morrison et al.28 reported
that for every one unit increase in childhood BMI percentile,
the odds ratio for developing the metabolic syndrome in
adulthood was 1.025. The other two studies had the oldest
adult cohorts. Bjorge et al.22 reported no significant increase
in risk of death from type 2 diabetes in men associated with
childhood obesity. It did not report results for women. The
final study by Salonen et al.17 reported that higher childhood
BMI was associated with lower risk of metabolic syndrome in
adult life. This was the only one of the four diabetes studies
that adjusted for adult adiposity, thus independent effects of
childhood BMI were not considered by most of the studies in
this area.
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Discussion
In developed countries, circulatory disease is the most
common cause of death, accounting for 33% of UK deaths
in 2008,30 and in Europe 48% of deaths are due to CVD.2 The
burden of disease is increasing owing to ageing populations
and the rising prevalence of obesity and its associated co-
morbidities. It is imperative to understand how events at
important stages across the lifespan influence long-term risk
of disease, so that interventions can be targeted to the most
appropriate time point. There is a widely held assumption
that childhood obesity is an independent risk factor for adult
metabolic and CVD. However, our previous review indicated
that the relationships are largely dependent on the tracking
of BMI from childhood to adulthood. Importantly, the
evidence suggested that the risk of raised blood pressure
was highest in those who were at the lower end of the BMI
scale in childhood and overweight in adulthood. The current
review has extended these findings to investigate the
relationship between childhood obesity and a range of
metabolic risk factors. Using an unbiased review methodol-
ogy, we found insufficient evidence to support the idea that
childhood obesity independently increases risk of dyslipi-
daemia and insulin resistance in adulthood. Conversely, and
in support of our previous analysis of blood pressure data,
the review demonstrates that those who were lean as
children seemed to be most susceptible to the metabolic
risk associated with adult obesity.
Our previous review10 focused on studies assessing CVD
end points and two major clinical risk factors for CVD, blood
pressure and carotid intima–media thickness. The quality
assessment of the studies included raised significant issues
regarding the quality of the data presented. In particular, the
studies assessing CVD end points were all retrospective in
nature, focused on non-contemporary populations and
failed to adjust for adult BMI. In contrast, the studies
assessing blood pressure and carotid intima–media thickness
were more likely to have adjusted for adult BMI, but often
involved adult cohorts with an average age considered too
young for the outcome to be assessed adequately. The
current review aimed to overcome these limitations to some
extent by assessing a range of intermediary risk factors.
Blood lipids
Dyslipidaemia is a widely recognised risk factor for progres-
sion of atherosclerosis,31 and is a component of the
metabolic syndrome and CVD. Adult obesity is generally
associated with dyslipidaemia and recent literature suggests
that the origins of dyslipidaemia may be determined in
childhood, in conjunction with obesity. Several studies have
demonstrated links between childhood obesity and raised
total cholesterol, LDL-cholesterol, triglycerides and low
HDL-cholesterol concentrations32,33 in adulthood. Impor-
tantly, blood lipid concentrations have been shown to track
from childhood to adulthood.34
This review demonstrates an overwhelming lack of
evidence of an independent positive relationship between
childhood BMI and dyslipidemia. Of the two studies that
reported positive associations between childhood BMI and
adult total cholesterol,19,23 only one adjusted for adult BMI,
and doing so reversed the direction of the relationship,19
suggesting that those with higher BMI in childhood had
lower total cholesterol in adulthood if overweight was not
maintained. An inverse association after adjustment for
adult BMI was also observed in women in the study by
Wright et al.20 Lauer et al.23 showed the strongest positive
association between childhood BMI and adult cholesterol,
but the data were not adjusted for adult BMI, despite a strong
degree of tracking of BMI from childhood into adulthood
(r¼0.53–0.84). Similarly for LDL-cholesterol, the positive
association with childhood BMI reported by Freedman
et al.19 became negative after adjustment for adult BMI,
suggesting that those with higher BMI in childhood had
lower LDL-cholesterol as adults if overweight was not
maintained. Negative correlations between childhood BMI
and HDL-cholesterol were reported by two studies. Once
again, adjustment for adult BMI in the Bogalusa Heart Study
rendered this relationship positive,19 while the other study
demonstrated a high degree of BMI tracking into adulthood
(r¼0.612), but did not make the adjustment.24 Similar
themes emerged in consideration of associations between
adult triglyceride concentrations and childhood BMI, with
negative association observed in the two studies that made
the adjustment for adult BMI.
Our review therefore found very little evidence to suggest
that greater BMI in childhood was an independent risk factor
for dyslipidaemia in adulthood. This is in agreement with
the findings of Porkka et al.,35 who reported that childhood
obesity variables (BMI and subscapular skinfold) were poor
predictors of adult serum levels and only accounted for
between 0 and 6% of adult lipid variability. In contrast to
commonly held assumptions and in agreement with our
previous review of blood pressure data, several studies
observed that those who had a higher BMI during childhood
exhibited lower total cholesterol, LDL-cholesterol and trigly-
cerides and higher HDL-cholesterol.
Insulin
Increased adiposity generally leads to systemic hyperinsuli-
naemia and decreased skeletal muscle sensitivity.36 Insulin
resistance is linked to a range of comorbidities, including
obesity, dyslipidaemia, type 2 diabetes and atherosclerotic
disease.37,38 Obese children have higher fasting insulin and
homeostasis model assessment-insulin resistance compared
with age-matched lean children.39,40 Clinically relevant
morbidities, however, remain unusual in children and
adolescents.41 Of the six studies that met the selection
criteria for this review, three18,19,24 reported moderate
positive correlations between childhood BMI and adult
insulin concentrations. However, only one of these adjusted
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for adult BMI and this reversed the direction of the
association observed, similar to the patterns observed in
the blood lipid data. The only study in support of an
association that is independent of adult BMI was that by
Thearle et al.,16 who reported a positive correlation between
childhood BMI and acute insulin response (and a negative
correlation with insulin action) when adjusted for adult
percentage body fat. Generally, the positive associations
between childhood BMI and insulin were slightly stronger
than those for blood lipids (range r¼ þ0.26 to þ0.36).
Although the clinical significance of these trends may not be
great, this may indicate a slightly stronger correlation
between adult BMI and insulin than that between adult
BMI and blood lipids. However, it must be noted that such
an assertion is dependent on the studies noted to be of lower
quality in this review. The Thearle study16 had some
important limitations when considering its relevance to a
wider population, as the cohort was very small (n¼76) and
limited to Pima Indians, a group known to be particularly
susceptible to type 2 diabetes.
Interesting negative associations were observed in two
other studies. Martin et al.21 reported that the heaviest
children were least likely to manifest as insulin resistant in
adulthood, particularly if they went on to be lean. Wright
et al.20 reported a negative association between childhood
BMI and insulin after adjustment for adult BMI. Although
study design and paucity of data made it difficult to draw
firm conclusions, the balance of available material does not
provide sufficient evidence to support an independent
detrimental effect of childhood obesity on adult insulin
status. Similarly to blood lipids, the data may instead
indicate that those who are heavier as children may be less
likely to exhibit insulin resistance as adults. We suggest that
this may relate to the greater contribution of lean mass to
weight and BMI during childhood, and its subsequent
involvement in regulating insulin sensitivity.
Disease outcomes
To extend the findings of our previous review of CVD
outcomes, the current review assessed the relationship
between childhood obesity and risk of metabolic syndrome
and type 2 diabetes. The International Diabetes Federation
estimates that 285 million people worldwide have diabetes
in 2010 and this will rise to 438 million by 2030.42 A similar
pattern is envisaged in the United Kingdom, with 2.6 million
people diagnosed in 2009, rising to over 4 million by 2025.43
Around 80% of those adults with type 2 diabetes also fulfil
the criteria for metabolic syndrome.44
Within the studies that met the inclusion criteria for this
review, evidence was presented of a positive correlation
between childhood BMI and the number of metabolic
syndrome criteria risk variables15 and risk of developing
the metabolic syndrome.28 In contrast, Salonen et al.17
reported a decreased risk of metabolic syndrome for those
with the highest childhood BMI and the largest study,22
which included over 225 000 subjects, found childhood BMI
was not linked to increased risk of type 2 diabetes mortality
in men. Taken together, these data fail to provide clear
evidence that high childhood BMI leads to increased risk of
diabetes and metabolic system morbidity or mortality. Few
studies have tested the hypothesis directly and weaknesses
were identified in those that did. For example, Morrison
et al.28 relied on self-reports of the presence of type 2
diabetes, which may have been associated with under-
reporting.
Final conclusions
To conclude, this systematic review has found little evidence
to support the view that childhood obesity is an indepen-
dent risk factor for adult blood lipid status, insulin levels,
metabolic syndrome or type 2 diabetes. The research for each
is generally insufficient, with the majority of studies failing
to adjust for adult BMI and therefore not able to assess the
relationship independently of the tracking of BMI and
associated biomarkers of metabolic disease across the life-
span. The study by Must et al.45 is often cited as demonstrat-
ing a link between adolescent obesity and long-term
mortality and morbidity that is independent of adult BMI.
However, this study did not meet the criteria for inclusion
within this review owing to the use of arbitrary cutoffs for
categorising overweight. In addition, the lean cohort only
covered a small range at the lower end of what is currently
considered to be normal weight and cannot be considered
representative of contemporary populations. This systematic
review provides a balanced summary of the available data
and concludes that there is insufficient evidence to demon-
strate links with long-term risk, which are independent of
adult BMI.
Interestingly, for those studies that did adjust for adult
BMI, the balance of data suggest that there is a weak negative
association between childhood obesity and metabolic vari-
ables, which could be interpreted as a slight protective effect
of obesity in childhood. Similar observations were observed
with regard to adult blood pressure in our previous review.
However, BMI is a measure of weight relative to height rather
than actual adiposity, and fat-free mass makes up a higher
proportion of BMI than fat mass in childhood compared
with adulthood.46 Relatively weak correlations between BMI
and percentage body fat have been observed in children and
adolescents.47 –50 Differences in BMI may therefore reflect
differences in fat-free mass, particularly among those at the
lower end of the BMI range.48 These observations make the
negative associations between childhood BMI and adult
metabolic risk (independent of adult BMI) particularly
interesting, as they may reflect the long-term consequences
of differences in the trajectory of lean mass deposition from
as early as childhood. More detailed study of the impact of
the trajectory of both fat and fat-free mass on future
metabolic and cardiovascular risk is required to address this
issue. The impact of diet and body composition during the
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developmental period on long-term metabolic function and
disease risk has been demonstrated in a range of epidemio-
logical studies, with biological plausibility and causality
demonstrated in experimental studies in animal models.51
We suggest that the susceptibility of long-term metabolic
function to diet and body composition extends throughout
the growth phase, and that the pattern of inverse associa-
tions, which has emerged from this systematic review, may
reflect the impact of ‘mismatch’ between the growth phase
and adult periods of the life course. Further work is required
to establish which physiological systems remain sensitive to
permanent change and to identify a threshold age below
which the inverse associations arise.
There is substantial evidence that childhood obesity tracks
into adulthood and it is clear that adult obesity conveys
higher risk of metabolic disease. We are not, therefore,
suggesting that childhood obesity is without consequences.
Targeting childhood and adolescence for prevention and
treatment of obesity is wholly appropriate to establish a
healthy weight moving forward into the adult years. However,
it is evident from this systematic review that the nature of the
relationship between early BMI and adult disease risk is very
complex. Those who are at the lower end of the BMI range in
childhood, but go on to be obese during adulthood seem to be
at particular risk. Focusing on children who are overweight or
obese for the promotion of healthy weight management may
therefore miss an important at-risk group.
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